Diet and Microbiome-Targeted Interventions for Functional Gut Disorders: Evidence and applications of pre and probiotics in IBS

This webinar is brought to you by the DA Gastroenterology Interest Group. 

25 November 2020 at 1:00-2:00pm (Canberra/Sydney/Melbourne, AEDT)

This webinar will explore diet and microbiome-targeted interventions for the management of patients with functional gut disorders, specifically focusing on the evidence and application of prebiotics and probiotics as therapy for IBS. 

Learning Outcomes: 

• Increased understanding of the pathophysiology of functional gut disorders (IBS)
• Increased knowledge and understanding of current medical and dietary management for IBS
• Increased knowledge and understanding on evidence and application of prebiotics and probiotics as therapy

Speaker:

Dr. Heidi Staudacher is a dietitian with extensive experience in the clinical management of individuals with gastrointestinal disorders. She undertook her PhD at King's College London in 2012 investigating the role of diet in irritable bowel syndrome. She has published numerous papers in the field, including the first placebo-controlled trial of low FODMAP dietary advice in IBS. These have helped to progress our understanding of the potential efficacy of diet to manager gut symptoms, but also the consequences of altering diet on the gut microbiota and dietary quality. At the Food & Mood Centre her research program focuses on the relationship between diet, the gut and mental health. 

This webinar is worth 1 CPD hour. 

Webinar access details will be sent out via email on 24 November 2020.